Discovering a new class of antifungal agents that selectively inhibits microbial carbonic anhydrases

References

• Baym M, Stone LK, Kishony R. Multidrug evolutionary strategies to reverse antibiotic resistance. Science 2016;351:aad3292.
   PubMed Web of Science ®Google Scholar
• Levy SB, Marshall B. Antibacterial resistance worldwide: causes, challenges and responses. Nat Med 2004;10:S122–9.
   PubMed Web of Science ®Google Scholar
• Ventola CL. The Antibiotic Resistance crisis: part 1: causes and threats. P T 2015;40:277–83.
   PubMedGoogle Scholar
• Revie NM, Iyer KR, Robbins N, Cowen LE. Antifungal drug resistance: evolution, mechanisms and impact. Curr Opin Microbiol 2018;45:70–6.
   PubMed Web of Science ®Google Scholar
• Brown ED, Wright GD. Antibacterial drug discovery in the resistance era. Nature 2016;529:336–43.
   PubMed Web of Science ®Google Scholar
• Supuran CT. Bacterial carbonic anhydrases as drug targets: toward novel antibiotics?. Front Pharmacol 2011;2:1–6.
   PubMed Web of Science ®Google Scholar
• Roemer T, Jiang B, Davison J, et al. Large-scale essential gene identification in Candida albicans and applications to antifungal drug discovery. Mol Microbiol 2003;50:167–81.
   PubMed Web of Science ®Google Scholar
• Brown JCS, Nelson J, VanderSluis B, et al. Unraveling the biology of a fungal meningitis pathogen using chemical genetics. Cell 2014;159:1168–87.
   PubMed Web of Science ®Google Scholar
• Annunziato G, Pieroni M, Benoni R, et al. Cyclopropane-1,2-dicarboxylic acids as new tools for the biophysical investigation of O-acetylserine sulfhydrylases by fluorimetric methods and saturation transfer difference (STD) NMR. J Enzyme Inhib Med Chem 2016;31:78–87.
   PubMed Web of Science ®Google Scholar
• Annunziato G, Angeli A, D'Alba F, et al. Discovery of new potential anti-infective compounds based on carbonic anhydrase inhibitors by rational target-focused repurposing approaches. ChemMedChem 2016;11:1876–914.
   Web of Science ®Google Scholar
• Magalhães J, Annunziato G, Franko N, et al. Integration of enhanced sampling methods with saturation transfer difference experiments to identify protein druggable pockets. J Chem Inf Model 2018;58:710–23.
   PubMed Web of Science ®Google Scholar
• Pieroni M, Annunziato G, Beato C, et al. Rational design, synthesis, and preliminary structure-activity relationships of α-substituted-2-phenylcyclopropane carboxylic acids as inhibitors of salmonella typhimurium O-acetylserine sulfhydrylase. J Med Chem 2016;59:2567–78.
   PubMed Web of Science ®Google Scholar
• Pieroni M, Azzali E, Basilico N, et al. Accepting the invitation to open innovation in malaria drug discovery: synthesis, biological evaluation, and investigation on the structure-activity relationships of benzo[b]thiophene-2-carboxamides as antimalarial agents. J Med Chem 2017;60:1959–70.
   PubMed Web of Science ®Google Scholar
• Supuran CT. Carbonic anhydrase inhibitors. Bioorg Med Chem Lett 2010;20:3467–74.
   PubMed Web of Science ®Google Scholar
• Capasso C, Supuran CT. An overview of the selectivity and efficiency of the bacterial carbonic anhydrase inhibitors. Curr Med Chem 2015;22:2130–9.
   PubMed Web of Science ®Google Scholar
• Capasso C, Supuran CT. Anti-infective carbonic anhydrase inhibitors: a patent and literature review. Expert Opin Ther Pat 2013;23:693–704.
   PubMed Web of Science ®Google Scholar
• Lionetto MG, Caricato R, Giordano ME, Schettino T. The complex relationship between metals and carbonic anhydrase: new insights and perspectives. Int J Mol Sci 2016;17:1–14.
   PubMed Web of Science ®Google Scholar
• Supuran CT. Carbonic anhydrases as drug targets-an overview. Curr Top Med Chem 2007;7:825–33.
   PubMed Web of Science ®Google Scholar
• Xu Y, Feng L, Jeffrey PD, et al. Structure and metal exchange in the cadmium carbonic anhydrase of marine diatoms. Nature 2008;452:56–61.
   PubMed Web of Science ®Google Scholar
• Supuran CT. Structure and function of carbonic anhydrases. Biochem J 2016;473:2023–32.
   PubMed Web of Science ®Google Scholar
• Chegwidden WR, Dodgson SJ, Spencer IM. The roles of carbonic anhydrase in metabolism, cell growth and cancer in animals. In: EXS. 2000:343–63.
   PubMedGoogle Scholar
• Supuran CT. Carbonic anhydrases: novel therapeutic applications for inhibitors and activators. Nat Rev Drug Discov 2008;7:168–81.
   PubMed Web of Science ®Google Scholar
• Supuran CT. Inhibition of bacterial carbonic anhydrases and zinc proteases: from orphan targets to innovative new antibiotic drugs. Curr Med Chem 2012;19:831–44.
   PubMed Web of Science ®Google Scholar
• Supuran CT, Scozzafava A, Casini A. Carbonic anhydrase inhibitors. Med Res Rev 2003;23:146–89.
   PubMed Web of Science ®Google Scholar
• Salek T, Andel I, Kurfurstova I. Topiramate induced metabolic acidosis and kidney stones – a case study. Biochem Med (Zagreb) 2017;27:404–10.
   PubMed Web of Science ®Google Scholar
• Alvarez BV, Quon AL, Mullen J, Casey JR. Quantification of carbonic anhydrase gene expression in ventricle of hypertrophic and failing human heart. BMC Cardiovasc Disord 2013;13:2.
   PubMed Web of Science ®Google Scholar
• Kossoff EH, Pyzik PL, Furth SL, et al. Kidney stones, carbonic anhydrase inhibitors, and the ketogenic diet. Epilepsia 2002;43:1168–71.
   PubMed Web of Science ®Google Scholar
• Pickkers P, Garcha RS, Schachter M, et al. Inhibition of carbonic anhydrase accounts for the direct vascular effects of hydrochlorothiazide. Hypertens Dallas Tex 1999;33:1043–8.
   PubMed Web of Science ®Google Scholar
• Rajasingham R, Smith RM, Park BJ, et al. Global burden of disease of HIV-associated cryptococcal meningitis: an updated analysis. Lancet Infect Dis 2017;17:873–81.
   PubMed Web of Science ®Google Scholar
• O'Halloran JA, Powderly WG, Spec A. Cryptococcosis today: it is not all about HIV infection. Curr Clin Microbiol Rep 2017;4:88–95.
   PubMed Web of Science ®Google Scholar
• Rossi SA, Trevijano-Contador N, Scorzoni L, et al. Impact of resistance to fluconazole on virulence and morphological aspects of Cryptococcus neoformans and Cryptococcus gattii isolates. Front Microbiol 2016;7:153.
   PubMed Web of Science ®Google Scholar
• Krysan DJ. Toward improved anti-cryptococcal drugs: Novel molecules and repurposed drugs. Fungal Genet Biol FG B 2015;78:93–8.
   PubMed Web of Science ®Google Scholar
• Mogensen EG, Janbon G, Chaloupka J, et al. Cryptococcus neoformans senses CO2 through the carbonic anhydrase Can2 and the adenylyl cyclase Cac1. Eukaryotic Cell 2006;5:103–11.
   PubMed Web of Science ®Google Scholar
• Schlicker C, Hall RA, Vullo D, et al. Structure and inhibition of the CO2-sensing carbonic anhydrase Can2 from the pathogenic fungus Cryptococcus neoformans. J Mol Biol 2009;385:1207–20.
   PubMed Web of Science ®Google Scholar
• Vallerini GP, Amori L, Beato C, et al. 2-Aminonicotinic acid 1-oxides are chemically stable inhibitors of quinolinic acid synthesis in the mammalian brain: a step toward new antiexcitotoxic agents. J Med Chem 2013;56:9482–95.
   PubMed Web of Science ®Google Scholar
• Campese VM. Minoxidil: a review of its pharmacological properties and therapeutic use. Drugs 1981;22:257–78.
   PubMed Web of Science ®Google Scholar
• Sirtori CR, Gianfranceschi G, Sirtori M, et al. Reduced triglyceridemia and increased high density lipoprotein cholesterol levels after treatment with acipimox, a new inhibitor of lipolysis. Atherosclerosis 1981;38:267–71.
   PubMed Web of Science ®Google Scholar
• Del Prete S, Vullo D, Fisher GM, et al. Discovery of a new family of carbonic anhydrases in the malaria pathogen Plasmodium falciparum–the η-carbonic anhydrases. Bioorg Med Chem Lett 2014;24:4389–96.
   PubMed Web of Science ®Google Scholar
• Bahn Y-S, Cox GM, Perfect JR, Heitman J. Carbonic anhydrase and CO2 sensing during Cryptococcus neoformans growth, differentiation, and virulence. Curr Biol CB 2005;15:2013–20.
   PubMed Web of Science ®Google Scholar
• Supuran CT, Capasso C. An overview of the bacterial carbonic anhydrases. Metabolites 2017;7:56.
   PubMed Web of Science ®Google Scholar
• Ferraroni M, Del Prete S, Vullo D, et al. Crystal structure and kinetic studies of a tetrameric type II β-carbonic anhydrase from the pathogenic bacterium Vibrio cholerae. Acta Crystallogr D Biol Crystallogr 2015;71:2449–56.
   PubMedGoogle Scholar
• Del Prete S, De Luca V, Vullo D, et al. A new procedure for the cloning, expression and purification of the β-carbonic anhydrase from the pathogenic yeast Malassezia globosa, an anti-dandruff drug target. J Enzyme Inhib Med Chem 2016;31:1156–61.
   PubMed Web of Science ®Google Scholar
• Tripp BC, Smith K, Ferry JG. Carbonic anhydrase: new insights for an ancient enzyme. J Biol Chem 2001;276:48615–8.
   PubMed Web of Science ®Google Scholar
• Loyse A, Bicanic T, Jarvis J. Combination antifungal therapy for cryptococcal meningitis. N Engl J Med 2013;368:2522–3.
   PubMedGoogle Scholar
• Sloan D, Dlamini S, Paul N, Dedicoat M. Treatment of acute cryptococcal meningitis in HIV infected adults, with an emphasis on resource-limited settings. Cochrane Database Syst Rev 2008;4:1–41.
   Google Scholar
• Capasso C, Supuran CT. Bacterial, fungal and protozoan carbonic anhydrases as drug targets. Expert Opin Ther Targets 2015;19:1689–704.
   PubMed Web of Science ®Google Scholar
• Schrödinger. Schrodinger, LLC. New York, 2015. Available from: https://www.schrodinger.com.
   Google Scholar
• Khalifah RG. The carbon dioxide hydration activity of carbonic anhydrase. I. Stop-flow kinetic studies on the native human isoenzymes B and C. J Biol Chem 1971;246:2561–73.
   PubMed Web of Science ®Google Scholar
• Modak JK, Liu YC, Supuran CT, Roujeinikova A. Structure-activity relationship for sulfonamide inhibition of Helicobacter pylori α-carbonic anhydrase. J Med Chem 2016;59:11098–109.
   PubMed Web of Science ®Google Scholar
• De Vita D, Angeli A, Pandolfi F, et al. Inhibition of the α-carbonic anhydrase from Vibrio cholerae with amides and sulfonamides incorporating imidazole moieties. J Enzyme Inhib Med Chem 2017;32:798–804.
   PubMed Web of Science ®Google Scholar
• Del Prete S, De Luca V, De Simone G, et al. Cloning, expression and purification of the complete domain of the η-carbonic anhydrase from Plasmodium falciparum. J Enzyme Inhib Med Chem 2016;31:54–9.
   PubMed Web of Science ®Google Scholar
• Capasso C, Supuran CT. An overview of the alpha-, beta- and gamma-carbonic anhydrases from bacteria: can bacterial carbonic anhydrases shed new light on evolution of bacteria?. J Enzyme Inhib Med Chem 2015;30:325–32.
   PubMed Web of Science ®Google Scholar
• Diaz JRA, Fernández Baldo M, Echeverría G, et al. A substituted sulfonamide and its Co (II), Cu (II), and Zn (II) complexes as potential antifungal agents. J Enzyme Inhib Med Chem 2016;31:51–62.
   PubMed Web of Science ®Google Scholar
• Ciociola T, Pertinhez TA, Giovati L, et al. Dissecting the structure-function relationship of a fungicidal peptide derived from the constant region of human immunoglobulins. Antimicrob Agents Chemother 2016;60:2435–42.
   PubMed Web of Science ®Google Scholar